Arkolith/Insider Trading/MURA/Form 4

Keson-Brookes Maiken

See RemarksMural Oncology plc (MURA) · full profile →Form 4 · filed Mar 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2025Sell(S)1K$3.45$5K74K
Mar 4, 2025Sell(S)1K$3.36$4K75K
Mar 3, 2025Grant(A)35K—$076K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2025Grant(A)65K—$065K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-033769) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML